DCF — ANMED HEALTH
Enterprise Value: $-301.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-301.4M
Enterprise Value
$-109.7M
PV of Cash Flows
$-191.7M
PV of Terminal Value
$-308.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $614.6M | $-11.0M | -2.0% | $-37.0M | $-33.6M |
| Year 2 | $633.0M | $-5.0M | -1.0% | $-31.8M | $-26.2M |
| Year 3 | $652.0M | $1.4M | 0.0% | $-26.2M | $-19.7M |
| Year 4 | $671.6M | $4.8M | 1.0% | $-23.6M | $-16.1M |
| Year 5 | $691.7M | $6.7M | 1.0% | $-22.6M | $-14.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-301.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$596.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.022832329518004887
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5